TSH Corp

Thread Rating:
  • 0 Vote(s) - 0 Average
  • 1
  • 2
  • 3
  • 4
  • 5
#31
There is a difference between selling a business unit (subsidiary) and sales of business (partial or whole) of a business unit.  The former involves the transfer of shareholding while the latter covers the transfer of assets (may include trademark, brand, value of customer relationship) and liabilities [no involvement of share transfer].

In my opinion, the above Quote on the sales/transfer of Explomo Shares to Anthony, equate to a sales of subsidiary.  Thus, all the assets (including cash) and liabilities of the subsidiary, Explomo [net value at S$2.97m], will be stripped from the Group for a purchase consideration of S$3.012m, payable to the investment holding company, Starmo which is turn owned by TSH.

The striking difference is the intangible value on Explomo accorded by TSH (while acquiring Starmo) compared to the value that CEO is willing to pay.  It is to note that the intangible value accorded is at different points in time, at a presumed more optimistic time when TSH acquired compared to the lesser interesting time with lower sales performance of Explomo when the CEO is contemplating buying.  Whether is it a fair deal is highly subjective, given that there is no competitive bid/taker.

Kind of remind me of a poster showing two signboards reading "we sell antique" at the shopfront, and "we collect junk" at its backdoor.

Purely just my take/interpretation on the above post. I do not know much about this company and its corporate development.
Reply
#32
Based on the latest circular announcement on SGX dated 13 July 2016. http://infopub.sgx.com/FileOpen/TSH_EGM_...eID=412512

Under "7.6 Use of Proceeds", "The Board intends to use part of the Net Property Proceeds as follows:
(a) approximately S$7.50 million towards the repayment of an existing bank loan; and
(b) approximately S$4.50 million towards the discharge of the mortgage on the Property."

However, according to the latest Annual Report, under 24. Borrowings, it shows that the company has 2 outstanding loans, A and B of 4.7M and 2.5M respectively.
http://infopub.sgx.com/FileOpen/TSH%20AR...leID=28833

I am unable to reconcile the difference. Any fellow VBs can help? Confused
Reply
#33
Capital Reduction - $0.1072/share
Special Dividend - $0.0160/share

Total - $0.1232/share ~ $29.6M

Market valuing the shell company at $3.6M at current share price of 13.8 cents.

http://infopub.sgx.com/FileOpen/Capital%...eID=421617
Reply
#34
(26-09-2016, 10:11 AM)yawnyawn Wrote: Capital Reduction - $0.1072/share
Special Dividend - $0.0160/share

Total - $0.1232/share ~ $29.6M

Market valuing the shell company at $3.6M at current share price of 13.8 cents.

http://infopub.sgx.com/FileOpen/Capital%...eID=421617

I think the computation should go like this: 

Cash as announced is already $33.69 mil or $0.14 per share. This does not include the Unilink stake carried at net realisable value of $2.98 mil (~$0.012/share). Assuming all other assets and liabilities as at 30 Jun remain the same and the Unilink stake sold at roughly the same price as carrying cost, you should have NTA per share of about $0.149 backed by cash of $0.152 per share. The current price of $0.14 is at a discount to the NTA and projected cash value if Unilink stake is sold. Market has not priced in any shell value as of now. 

In any case, being a value investor, I usually do not assign any value to the shell because it is contingent upon an RTO and not a real tangible value per se.
Reply
#35
(26-09-2016, 12:00 PM)Debronic Wrote:
(26-09-2016, 10:11 AM)yawnyawn Wrote: Capital Reduction - $0.1072/share
Special Dividend - $0.0160/share

Total - $0.1232/share ~ $29.6M

Market valuing the shell company at $3.6M at current share price of 13.8 cents.

http://infopub.sgx.com/FileOpen/Capital%...eID=421617

I think the computation should go like this: 

Cash as announced is already $33.69 mil or $0.14 per share. This does not include the Unilink stake carried at net realisable value of $2.98 mil (~$0.012/share). Assuming all other assets and liabilities as at 30 Jun remain the same and the Unilink stake sold at roughly the same price as carrying cost, you should have NTA per share of about $0.149 backed by cash of $0.152 per share. The current price of $0.14 is at a discount to the NTA and projected cash value if Unilink stake is sold. Market has not priced in any shell value as of now. 

In any case, being a value investor, I usually do not assign any value to the shell because it is contingent upon an RTO and not a real tangible value per se.

If a RTO does materialize, how does one value it? It seems like at $0.150, value is more or less fully realized at this point. For a novice investor who cannot value a potential RTO, it seems like my capital in TSH can be better deployed elsewhere with better prospects.
Reply


Forum Jump:


Users browsing this thread: 1 Guest(s)